These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 10575406

  • 1. Risk factors for erythema nodosum leprosum.
    Manandhar R, LeMaster JW, Roche PW.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [Abstract] [Full Text] [Related]

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 3. Does clofazimine prevent erythema nodosum leprosum (ENL) in leprosy? A retrospective study, comparing the experience of multibacillary patients receiving either 12 or 24 months WHO-MDT.
    Balagon M, Saunderson PR, Gelber RH.
    Lepr Rev; 2011 Sep; 82(3):213-21. PubMed ID: 22125929
    [Abstract] [Full Text] [Related]

  • 4. Clinical course of erythema nodosum leprosum: an 11-year cohort study in Hyderabad, India.
    Pocaterra L, Jain S, Reddy R, Muzaffarullah S, Torres O, Suneetha S, Lockwood DN.
    Am J Trop Med Hyg; 2006 May; 74(5):868-79. PubMed ID: 16687695
    [Abstract] [Full Text] [Related]

  • 5. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM.
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [Abstract] [Full Text] [Related]

  • 6. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M, Berhe D.
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [Abstract] [Full Text] [Related]

  • 7. Epidemiological characteristics of leprosy reactions: 15 years experience from north India.
    Kumar B, Dogra S, Kaur I.
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):125-33. PubMed ID: 15301592
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Histoid leprosy: a retrospective study of 40 cases from India.
    Kaur I, Dogra S, De D, Saikia UN.
    Br J Dermatol; 2009 Feb; 160(2):305-10. PubMed ID: 19016704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Reactional states in multibacillary Hansen disease patients during multidrug therapy.
    Nery JA, Vieira LM, de Matos HJ, Gallo ME, Sarno EN.
    Rev Inst Med Trop Sao Paulo; 1998 Feb; 40(6):363-70. PubMed ID: 10436656
    [Abstract] [Full Text] [Related]

  • 13. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
    Kumar A, Girdhar A, Girdhar BK.
    Acta Leprol; 2003 Feb; 12(3):123-8. PubMed ID: 15040703
    [Abstract] [Full Text] [Related]

  • 14. [Histoid leprosy with erythema nodosum leprosum].
    Alioua Z, Sbai M, Elhaouri M, Bouzidi A, Boudi O, Ghfir M, Benomar S, Sedrati OL.
    Acta Leprol; 2003 Feb; 12(3):107-11. PubMed ID: 15040700
    [Abstract] [Full Text] [Related]

  • 15. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
    Santaram V, Porichha D.
    Indian J Lepr; 2004 Feb; 76(4):310-20. PubMed ID: 16119141
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
    Rodríguez G, Pinto R, López F, Gómez Y.
    Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
    [Abstract] [Full Text] [Related]

  • 19. Some unusual type 2 reactions in leprosy.
    Ramesh V, Pahwa M.
    Int J Dermatol; 2010 Feb; 49(2):172-5. PubMed ID: 20465641
    [Abstract] [Full Text] [Related]

  • 20. Joint chemotherapy trials in lepromatous leprosy conducted in Thailand, the Philippines, and Korea.
    Cellona RV, Fajardo TT, Kim DI, Hah YM, Ramasoota T, Sampattavanich S, Carrillo MP, Abalos RM, dela Cruz EC, Ito T.
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):1-11. PubMed ID: 2181040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.